Pharma 2024 _ Event Postponement
We would like to inform you that due to unforeseen circumstances beyond the organizer control, the "11th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems" (Pharma-2024), originally scheduled for March 18-20 in Singapore, has been rescheduled to take place from September 19-21, 2024, in Rome, Italy.
If you have already confirmed your participation at the event, please note that your registration and accommodation (if previously booked with us) will automatically be transferred to the new dates.
For any further information or inquiries, please do not hesitate to contact us at pharmadds@magnusconference.com or call us at +1 (702) 988 2320.
Title: A Novel Approach to Terminate the COVID-19 Pandemic
Title: Diagnosing and prognosticating disease with high throughput immune receptor sequencing and machine learning
Title: Discovery of Influenza polymerase PA-PB1 Interaction Inhibitors Using an In Vitro Split-Luciferase Complementation-based Assay
Title: Biocompatible nanoparticles as a novel vaccine adjuvant
Title: Progress report on molecular characterization of measles virus in central African Republic: 2013-2016
Title: Sterilization of the hearts of Rattusnorvegicus Sprague Dawley from experimental endocarditis by E. faecalis ATCC 29212 with generic vancomycin
Title: Strategy to cohort potential COVID-19 patients in inpatient medical care: Is clinical judgement enough?
Title: Diagnosis and Management on Infected or Suspected Patients with Covid-19---48 Cases study in UK
Title: Evaluation of antifungal activity ofcarbosilane cationic dendritic molecules against Candida albicans biofilms
Title: Use of Sound Spectral Analysis as Process Analytical Technology (PAT) Tool in Topical Formulations Development
Title: Awareness and knowledge of congenital cytomegalovirus infection among health care providers and health students in France in 2019
Title: Identification and characterization of a multifunctional bioactive peptide from the archaeal kingdom
Title: Simultaneous MOR/DOR targeting as useful strategy for pain management.
Title: Design New Inhibitor Candidates for SARS- Cov- 2 RNA Depended Polymerase: A Computational Study
Title: 1. Energy Alterations and Chakras Energy Deficiencies and Propensity to Coronavirus Infection 2. Can we Treat Urinary Tract Infections without Using Any Antibiotics?
Title: Interaction of triatomine immune system, the Trypanosoma cruzi and the microbiota
Title: Perspectives for the development of strategies (drugs and non-drug therapies) for the reduction of inflammation, injury, and muscle recovery biomarkers
Title: Dengue RNA Detection Using Gold Nanoparticle-Based Lateral Flow Biosensor
Title: Green Wide-spectrum Anti-pathogenic Agent and its Personal Protective Devices
Title: Ameliorating effect and mechanism of Ma-Xing-Shi-Gan-Decoction*, a compound Chinese medicine on pulmonary microcirculatory disturbance
Title: Walk-Through screening system for COVID-19
Title: A Quality improvement approach to reduce infections in neonatal intensive care
Title: Application of Computer-Guided Drug Repurposing to the Discovery of New Potential Treatments for Infectious Diseases
Title: How to bind a novel virus; SARS-CoV-2 on their host?
Title: The Influence of Dipeptidyl Peptidase-IV Inhibitor on Testicular Ischemic Injury in Rats
Title: Glycyrrhizin ameliorates high fat diet-induced obesity in rats by activating NrF2 pathway
Title: Covid-19 genetic- clinical behavior
Title: Can TGF-β1 be a significant marker molecule in Non-alcoholic fatty liver disease?
Title: Design, Synthesis and pharmacological activity of triazine based chalcones
Title: Effect of hydroalcoholic extract of Juglans regia hull on isoprenaline induced testicular toxicity in Wistar rats
Title: Promoting Traditional Healthcare research in Post Covid-19 Era
Title: Biocomposite Scaffolds Impregnated with Liposomes for Local Drug Delivery to Oral Lesions.
Title: Fever is not a symptom in covid-19 None of the diseases require fever as its symptom
Title: Novel Corona Virus: A Global Threat and Recent Treatments Advances
Title: Newly diagnosed case with Gilbert Syndrome after 20 years suffering fro jaundice
Title: Saliva sample in diagnosis of 2019-NCOV as alternative to nasopharyngeal swab
